FRA:BIG1 - Deutsche Boerse Ag - DE000BGAG981 - Common Stock - Currency: EUR
FRA:BIG1 (6/2/2025, 7:00:00 PM)
1.04
+0.03 (+2.97%)
The current stock price of BIG1.DE is 1.04 EUR. In the past month the price increased by 30%. In the past year, price increased by 1.96%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GIN.DE | GIVAUDAN-REG | 34.27 | 40.84B | ||
SIKA.DE | SIKA AG-REG | 28.02 | 37.28B | ||
DSFIR.AS | DSM-FIRMENICH AG | 103.94 | 25.96B | ||
6D81.DE | DUPONT DE NEMOURS INC | 15.58 | 24.72B | ||
BRG.OL | BORREGAARD ASA | 21.48 | 18.82B | ||
SY1.DE | SYMRISE AG | 31.15 | 14.89B | ||
ELK.OL | ELKEM ASA | 17.61 | 12.84B | ||
1COV.DE | COVESTRO AG | N/A | 11.36B | ||
AKZA.AS | AKZO NOBEL N.V. | 16.06 | 10.18B | ||
EVK.DE | EVONIK INDUSTRIES AG | 29.78 | 8.88B | ||
SYENS.BR | SYENSQO SA | 14.52 | 7.20B | ||
AMC.DE | ALBEMARLE CORP | N/A | 5.84B |
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
BIO-GATE AG
Neumeyerstrasse 28-34
Nuremberg BAYERN DE
Employees: 45
Phone: 49911477523100
The current stock price of BIG1.DE is 1.04 EUR. The price increased by 2.97% in the last trading session.
The exchange symbol of BIO-GATE AG is BIG1 and it is listed on the Deutsche Boerse Ag exchange.
BIG1.DE stock is listed on the Deutsche Boerse Ag exchange.
8 analysts have analysed BIG1.DE and the average price target is 3.37 EUR. This implies a price increase of 223.65% is expected in the next year compared to the current price of 1.04. Check the BIO-GATE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIO-GATE AG (BIG1.DE) has a market capitalization of 9.61M EUR. This makes BIG1.DE a Nano Cap stock.
BIO-GATE AG (BIG1.DE) currently has 45 employees.
BIO-GATE AG (BIG1.DE) has a support level at 0.65. Check the full technical report for a detailed analysis of BIG1.DE support and resistance levels.
The Revenue of BIO-GATE AG (BIG1.DE) is expected to grow by 4.65% in the next year. Check the estimates tab for more information on the BIG1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BIG1.DE does not pay a dividend.
BIO-GATE AG (BIG1.DE) will report earnings on 2025-09-08.
BIO-GATE AG (BIG1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).
ChartMill assigns a technical rating of 9 / 10 to BIG1.DE. When comparing the yearly performance of all stocks, BIG1.DE is one of the better performing stocks in the market, outperforming 91.38% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. While BIG1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS decreased by -33.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -45.48% | ||
ROE | -87.45% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to BIG1.DE. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -37.5% and a revenue growth 4.65% for BIG1.DE